A Senate committee Wednesday passed a measure that would give area residents a chance to vote on whether to pay higher taxes to expand the mass-transit system. Lawmakers sent the bill to the Senate Tax and Fiscal Policy Committee.
A confluence of circumstances has led to a spurt of sales that sometimes occur within days.
The debate over expanding Medicaid in Indiana so far has hinged on how much it will cost. But two recent studies suggest Hoosier employers should be focused on how much a Medicaid expansion will save them: perhaps as much as $400 million per year.
House Bill 1315, which is scheduled for a Senate floor hearing on Monday, would require pharmacists to check with a patient’s physician before automatically substituting a generic version of a biotech drug for a brand-name version.
Journalists from San Francisco to D.C. and from New Haven to New Orleans descend on Indy for a first-ever critical mass of theater.
Years ago, Murphy observed, “If anything can go wrong, it will.” Murphy’s law has endured because, although we might chuckle, it rings of truth.
As important as business planning is, the path to success is rarely without obstacles—or opportunities. Savvy entrepreneurs like Janell Shaffer and Danielle McDowell recognize that and adjust along the way.
A jury Friday awarded $8.3 million to a former prison guard who accused Warsaw-based DePuy Orthopaedics of knowingly marketing a faulty hip implant that was later recalled, according to the Associated Press. Jurors found that the ASR XL implant was defectively designed and caused metal poisoning and other health problems suffered by Loren Kransky after he underwent surgery in 2007. The fraud and negligence suit is the first of nearly 11,000 similar cases involving an all-metal ball-and-socket hip joint that was pulled from the market two years ago to reach trial in the United States. Others like Kransky claim the implants have left them with crippling injuries or in need of other replacement surgeries. DePuy, a subsidiary of New Jersey-based Johnson & Johnson, has set aside about $1 billion to cover costs of the recall and lawsuits.
Eli Lilly and Co. has built up a stockpile of $21 billion in overseas profits as the nation’s largest drugmakers continue to use accounting mechanisms to avoid paying U.S. taxes. According to an analysis by Bloomberg News, the nation's six biggest drugmakers avoided paying $7.05 billion in U.S. taxes last year by shifting their profits overseas—nearly double the savings they achieved a decade ago. Now those legal practices are getting increased scrutiny from members of Congress. “The right kind of tax reform could do a lot to bring corporate profits back to the United States for investment and job creation,” said Charles Grassley, a U.S. senator from Iowa, in an e-mail to Bloomberg. “The current system provides an incentive for companies to keep money overseas indefinitely.” By moving patents and trademarks overseas, drugmakers can legally record sales of their products in foreign countries, avoiding any U.S. taxes until those profits are brought back into the United States. The maneuvers helped Lilly boost its earnings per share by 16 percent last year, according to Bloomberg. Other companies increased their earnings even more. Lilly declined to comment on the story.
IUPUI students can now pursue an academic minor in neuroscience, in addition to the neuroscience major that began in the fall. The School of Science at IUPUI launched its new neuroscience program to “take advantage of a booming neuroscience industry in Indiana and across the country,” according to a statement issued March 4. The school noted that the Indiana University Health hospital system recently opened a $120 million neuroscience center next to Methodist Hospital. And the IU School of Medicine is building a neuroscience research center next door to the IU Health facility. Neuroscience is one of several fast-growing segments of the life sciences industry in Indiana. A forecast by the Indiana Department of Workforce Development predicts that life scientist positions will increase by more than 22 percent in the next five years.
Rep. Ed Clere, R-New Albany, said his bill on land banks may have tried to tackle too many issues involving abandoned housing, including Indiana’s tax-sale process.
The interim superintendent of Indianapolis Public Schools is taking steps to shore up the struggling district, but says she faces a "complex job" that won't bring miracles during her tenure.
Many would-be applicants start off with content that fails to set them apart or showcase the key benefits they bring to the table.
A few years ago at a dinner in Washington, D.C., with some of the nation’s leading education reformers, one of them asked if I knew about The Mind Trust.
The position is meant to be more than a glorified tech support desk. It should be the office where infrastructure growth is planned and merged with the company’s overall goals.
Indianapolis-based CountryMark hopes an Indiana oil field that once was the largest in the United States can be lucrative again.
Eli Lilly and Co. has sued Roche Holding AG’s Genentech unit, asking a court to invalidate patents used to make treatments for cancer and autoimmune diseases, Bloomberg News reported. Lilly wants a court to reaffirm the patents behind its own cancer drug Erbitux. According to Lilly’s lawsuit, filed Thursday in federal court in San Francisco, Genentech deceived the U.S. Patent Office into issuing patents known as “Cabilly” after one of the inventors. Genentech claims that the process and certain starting materials used to produce Erbitux infringe on parts of the patents, and is pursuing an “aggressive litigation policy to protect its products against competition,” according to the complaint. Erbitux, made by Indianapolis-based Lilly’s ImClone unit, is approved in the United States to treat colon cancer and head and neck tumors. Lilly realized about $400 million in revenue from the drug in 2012. A phone call to Genentech’s media office seeking comment about the lawsuit wasn’t immediately returned.
Indianapolis-based CHV Capital joined Kaiser Permanente Ventures to invest an $8 million funding round for Health Catalyst, a Salt Lake City-based data warehousing company. The company already had raised $33 million in Series B funding to develop its technology, which helps hospitals measure quality data from their electronic medical record systems and report it to regulatory agencies and health insurers. Indiana University Health, the hospital system that is the parent of CHV Capital, already is using Health Catalyst’s technology.
The Indiana Senate voted last week to expand Medicaid using the state-run Healthy Indiana Plan. According to the Associated Press, Gov. Mike Pence and the Republican-led General Assembly have beat back efforts by Democrats to expand coverage using the traditional federal-state Medicaid program for the poor. Instead, they say, expansion should be done through the Healthy Indiana Plan or a similar state-run program, giving the state more control over costs. Expanding HIP would cost the state roughly 3 percent less than expanding Medicaid, state actuary Milliman Inc. estimated on Feb. 25. And supporters say HIP would promote more responsible decisions by enrollees. On the table is an expected $10.5 billion in federal aid for the state over the next seven years. But expanding HIP also could cost the state close to $2 billion over the period. House Speaker Brian Bosma, R-Indianapolis, said Tuesday that Pence likes the Senate's request for block grants from the federal government instead of matching funds for Indiana’s spending, as is the case with traditional Medicaid. "At least the leadership is all in favor of not using Medicaid expansion as the vehicle here because of the potential for massive cost in the future," Bosma said. Seven Democratic senators voted with all of the chamber's Republicans for the expansion, despite reservations about using HIP. "We don't agree with the bill the way it was written, but we want to make sure it remains alive," said Sen. Karen Tallian, D-Portage. Tallian asked lawmakers to approve a temporary expansion of Medicaid, for two years, similar to what Florida Gov. Rick Scott, a Republican, is supporting. But her amendment and similar efforts in the House failed.
Warsaw-based Zimmer Holdings Inc. said the U.S. Securities and Exchange Commission and the U.S. Department of Justice have ended their investigation into a possible violation by Zimmer of the Foreign Corrupt Practices Act. The investigation dates to September 2007. Zimmer is the world’s largest maker of orthopedic implants.
The National Science Foundation has awarded $500,000 to West Lafayette-based Tymora Analytical Operations LLC via a Phase II Small Business Innovation Research grant. Tymora will use the two-year grant to develop a technology called pIMAGO that helps lab researchers identify new targets for drugs to fight such diseases as cancer, diabetes, neurological disorders and immune system disorders. Tymora, founded by two Purdue University professors, has also received $450,000 in previous grants from the National Institutes of Health.
When the longtime CEO of United Way of Central Indiana last year announced her plans to retire, the not-for-profit’s board embarked on a search for a seasoned executive with deep community ties. They found both in Ann D. Murtlow.
Ann Murtlow has no experience running a not-for-profit, yet she is charging into the top job at one of the city’s largest charitable groups. The people who hired the former Indianapolis Power & Light Co. CEO say her connections to the Indianapolis business community are a big plus in her new role at United Way of Central Indiana.
The Indianapolis-based bank, launched just 14 years ago, is reaching all-time highs in assets and profitability and plans to become a $1 billion institution by 2015.
Former Indianapolis Power & Light Co. CEO Ann Murtlow will take the helm of the United Way of Central Indiana on April 1, the organization announced Wednesday afternoon. She’ll be the first new chief at the local not-for-profit since 1998.
Do the politicians care what nonvoters think? House Speaker Brian Bosma recently took issue with the WISH-TV/Ball State Hoosier Survey because, he said, it wasn’t a voter poll. When challenged, he said that he cares what everybody thinks, but the message he delivered was that the opinions of voters matter more than those of adults […]
